Arcutis Biotherapeutics, Inc.
ARQT· Nasdaq
ARQTArcutis Biotherapeutics, Inc.
Filed Nov 5, 2020 · 10-Q · 36 days after period end · 0001628280-20-015774
| Metric | Q3 2020 | Q3 2019 |
|---|---|---|
| Net Income | -$38.20M | -$14.48M |
| EPS Diluted | -$1.01 | -$7.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcutis Biotherapeutics, Inc. · CIK 1787306 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 5, 2020 · 36 d after period end
